Tag: tecentriq
-
Roche lung cancer drug success adds to pressure on Bristol
By Ben Hirschler COPENHAGEN (Reuters) – Lung cancer patients on Roche’s immune system-boosting drug Tecentriq lived on average 4.2 months longer than those taking chemotherapy in a pivotal study, pressuring Bristol-Myers Squibb’s dominant position in the field. The trial involved second-line patients, who have already used chemotherapy, and it found the Roche drug worked even…
-
Medics dash to rural Haiti as cholera kills 13 in Matthew’s wake
By Makini Brice and Joseph Guyler Delva PORT SALUT, Haiti/PORT-AU-PRINCE (Reuters) – Cholera has killed at least 13 people in southwest Haiti in the wake of Hurricane Matthew, officials said on Saturday, as government teams fanned out across the hard-hit southwestern tip of the country to repair treatment centers and reach the epicenter of one…
-
Far from Hurricane Matthew, a Haitian crisis flares in Tijuana
By Lizbeth Diaz TIJUANA, Mexico (Reuters) – The havoc wreaked by Hurricane Matthew has strengthened the resolve of thousands of Haitians stuck on the U.S.-Mexico border to make it to the United States even though new rules mean they will likely be deported to their shattered homeland. A surge in the number of Haitians seeking…